Cristina Caramés - Concepedia

Author

Cristina Caramés

Hospital Universitario Fundación Jiménez Díaz ORCID

Also Known As

C Carames, C Caramés, C. Carames, Cristina Carames, Cristina Caramés, Cristina Caramés Sánchez

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Fundación Jiménez Díaz Universidad Autónoma de Madrid Hospital Del Mar INCLIVA Health Research Institute Centre for Biomedical Network Research on Rare Diseases

About

Cristina Caramés is an author at Hospital Universitario Fundación Jiménez Díaz specializing in medicine, colorectal cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	425
2	Cell Biology	5	5	364
3	Health Sciences	1	1	30
4	Public Health	1	1	14
5	Social Sciences	1	1	139

Cristina Caramés

Publications

896

Citations

H-Index

Page 1

	Year	Citations
Phosphoinositide-3-Kinase Activation Controls Synaptogenesis and Spinogenesis in Hippocampal Neurons Germán Cuesto, Lilian Enríquez-Barreto, Cristina Caramés, Journal of Neuroscience NeurotransmitterPi3k-activating Transduction PeptideNeurotransmissionSynaptic SignalingSocial Sciences	2011	139
PP2A Inhibition Is a Common Event in Colorectal Cancer and Its Restoration Using FTY720 Shows Promising Therapeutic Potential Ion Cristóbal, Rebeca Manso, Raúl Rincón, Molecular Cancer Therapeutics Tumor BiologyOncologyChemoprevention StrategyCommon EventPp2a Activity	2014	124
Activation of MET pathway predicts poor outcome to cetuximab in patients with recurrent or metastatic head and neck cancer Juan Madoz‐Gúrpide, Sandra Zazo, Cristina Chamizo, Journal of Translational Medicine	2015	83
Deregulation of the PP2A Inhibitor SET Shows Promising Therapeutic Implications and Determines Poor Clinical Outcome in Patients with Metastatic Colorectal Cancer Ion Cristóbal, Raúl Rincón, Rebeca Manso, Clinical Cancer Research	2014	75
KRAS and BRAF Mutations as Prognostic and Predictive Biomarkers for Standard Chemotherapy Response in Metastatic Colorectal Cancer: A Single Institutional Study Nuria Garcia-Carbonero, Javier Martínez‐Useros, Weiyao Li, Cells	2020	74
MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer Cristina Caramés, Ion Cristóbal, Víctor Moreno, International Journal of Colorectal Disease OncologyMicrorna-21 Predicts ResponseMedicineColorectal CancerPreoperative Chemoradiotherapy	2015	47
Autocrine CCL5 Effect Mediates Trastuzumab Resistance by ERK Pathway Activation in HER2-Positive Breast Cancer Sandra Zazo, Paula Gónzález-Alonso, Ester Martı́n-Aparicio, Molecular Cancer Therapeutics	2020	40
Hyperphosphorylation of PP2A in colorectal cancer and the potential therapeutic value showed by its forskolin-induced dephosphorylation and activation Ion Cristóbal, Raúl Rincón, Rebeca Manso, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease Potential Therapeutic ValueForskolin-induced DephosphorylationSignal TransductionSignaling PathwayMedicine	2014	34
The Hippo Pathway Transducers YAP1/TEAD Induce Acquired Resistance to Trastuzumab in HER2-Positive Breast Cancer Paula Gónzález-Alonso, Sandra Zazo, Ester Martı́n-Aparicio, Cancers	2020	34
MicroRNA-31 Emerges as a Predictive Biomarker of Pathological Response and Outcome in Locally Advanced Rectal Cancer Cristina Caramés, Ion Cristóbal, Víctor Moreno, International Journal of Molecular Sciences Surgical OncologyPathologyCancer BiologyTumor BiologyGastrointestinal Oncology	2016	30

Page 1